Global Precision Cancer Imaging Market Growth (Status and Outlook) 2025-2031

According to this study, the global Precision Cancer Imaging market size will reach US$ million by 2031.

Precision cancer imaging system performs an important role in the detection of cancer because it offers a detailed perception into the exact location and extent of the ailment. Precision Cancer imaging is a technique for diagnosing scientific disorders, which takes into account individual variability in genetic and environmental factors. Precision cancer imaging system presents exact facts about the structural or cancer associated changes.

United States market for Precision Cancer Imaging is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Precision Cancer Imaging is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Precision Cancer Imaging is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Precision Cancer Imaging players cover GE, Hologic, Philips, Hitachi, Shimadzu, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Precision Cancer Imaging Industry Forecast” looks at past sales and reviews total world Precision Cancer Imaging sales in 2024, providing a comprehensive analysis by region and market sector of projected Precision Cancer Imaging sales for 2025 through 2031. With Precision Cancer Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Precision Cancer Imaging industry.

This Insight Report provides a comprehensive analysis of the global Precision Cancer Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Precision Cancer Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Precision Cancer Imaging market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Precision Cancer Imaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Precision Cancer Imaging.

This report presents a comprehensive overview, market shares, and growth opportunities of Precision Cancer Imaging market by product type, application, key players and key regions and countries.

Segmentation by Type:
Magnetic Resonance Imaging
Nuclear Imaging
Ultrasound Imaging
Others

Segmentation by Application:
Hospitals
Diagnostic Centers
Research Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE
Hologic
Philips
Hitachi
Shimadzu
Siemens
Fujifilm Holdings
Carestream Health
Esaote

Please note: The report will take approximately 2 business days to prepare and deliver. Show more